Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis

Mult Scler Relat Disord. 2023 Feb:70:104492. doi: 10.1016/j.msard.2022.104492. Epub 2022 Dec 29.

Abstract

Background: Cognitive impairment is common in people living with neuromyelitis optica spectrum disease (NMOSD) and multiple sclerosis (MS). However, there is little published data on intelligence quotient (IQ) in NMOSD patients. Therefore, we performed the present study to compare IQ scores across NMOSD, MS, and control groups.

Method: In this cross-sectional study, 49 NMOSD (30 with positive aquaporin4 antibody), 41 MS, and 20 control individuals were recruited. The IQ score for each person was measured using Wechsler Adult Intelligence Scale-Revised (WAIS-R). Participants were reported on eleven scores of subsets, verbal IQ (VIQ), performance IQ (PIQ), and full score IQ (FSIQ).

Result: The scores of FSIQ, VIQ, PIQ, vocabulary, similarities, and digit-symbol in NMOSD and MS individuals were lower than the control group. Relative to control, NMOSD patients reported a lower score of information. We found no difference between NMOSD and MS groups, except in vocabulary and similarities. No significant difference between seropositive and seronegative NMOSD groups was observed except for the information and block design. In NMOSD group, a greater EDSS score was associated with decreased scores of FSIQ, VIQ, and PIQ. Being employed and being married were associated with greater scores of VIQ and PIQ, respectively. In both NMOSD and MS groups, advanced education was associated with increased scores of FSIQ and VIQ.

Conclusion: Our study showed decreased IQ scores in NMOSD and MS. Further studies are required to examine intellectual quotient in people with NMOSD and MS.

Keywords: Cognition; Intelligence quotient; Multiple sclerosis; Nueromyelitis optica; Wechsler adult intelligence scale.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Humans
  • Intelligence
  • Intelligence Tests
  • Multiple Sclerosis*
  • Neuromyelitis Optica*